SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-21-278351
Filing Date
2021-09-21
Accepted
2021-09-21 16:32:02
Documents
2
Group Members
ANSBERT GADICKEBIOIMPACT CAPITAL LLCEDWARD HURWITZLUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV2014 LLCMPM ASSET MANAGEMENT INVESTORS BV2018 LLCMPM BIOVENTURES 2014 (B), L.P.MPM BIOVENTURES 2014 GP LLCMPM BIOVENTURES 2014 LLCMPM BIOVENTURES 2018 (B), L.P.MP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d212808dsc13da.htm SC 13D/A 374055
2 EX-99.C d212808dex99c.htm EX-99.C 24479
  Complete submission text file 0001193125-21-278351.txt   400738
Mailing Address C/O MPM ASSET MANAGEMENT LLC 450 KENDALL STREET CAMBRIDGE MA 02142
Business Address C/O MPM ASSET MANAGEMENT LLC 450 KENDALL STREET CAMBRIDGE MA 02142 (617) 425-9200
MPM BioVentures 2014, L.P. (Filed by) CIK: 0001609492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 857-204-4583
iTeos Therapeutics, Inc. (Subject) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91596 | Film No.: 211266856
SIC: 2836 Biological Products, (No Diagnostic Substances)